Frankfurt - Delayed Quote EUR
Amgen Inc. (AMG.F)
243.30
+1.50
+(0.62%)
At close: May 9 at 9:55:27 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 22 | 21 | 30 | 30 |
| Avg. Estimate | 8.85B | 8.91B | 35.2B | 35.87B |
| Low Estimate | 8.6B | 8.68B | 34.4B | 34.78B |
| High Estimate | 9.2B | 9.1B | 35.94B | 37.41B |
| Year Ago Sales | 8.39B | 8.5B | 33.42B | 35.2B |
| Sales Growth (year/est) | 5.50% | 4.74% | 5.30% | 1.90% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AMG.F | -- | -- | -- | -- |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Maintains | Mizuho: Neutral to Neutral | 5/7/2025 |
| Maintains | UBS: Neutral to Neutral | 5/2/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 5/2/2025 |
| Maintains | UBS: Neutral to Neutral | 4/14/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/9/2025 |
| Maintains | B of A Securities: Underperform to Underperform | 3/5/2025 |
Related Tickers
IDP.SG Biogen Inc
105.20
-0.94%
LLY.F Eli Lilly and Company
662.30
+0.75%
MRK.MX Merck & Co., Inc.
1,479.10
-2.75%
6MK.DE Merck & Co., Inc.
69.00
-0.14%
RHO5.HM Roche Holding AG
275.20
-1.26%
NOT.HM NOVARTIS AG N
97.06
-0.92%
GIS.F Gilead Sciences, Inc.
86.48
+0.10%
LLY.MX Eli Lilly and Company
14,400.00
-2.79%
SNW.F Sanofi
92.99
+0.86%
NOV.F Novo Nordisk A/S
59.33
+1.16%